TNBC Gut Microbiota During Neoadjuvant Treatment

Recruiting N/A Interventional Study
Breast Cancer Triple Negative Breast Cancer Early Stage Triple-Negative Breast Carcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
30 (estimated)
Sponsor
Scripps Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The gut microbiome is made up of the microbes (such as bacteria, viruses, and other organisms too small to see with the naked eye) that live in the digestive tract and has been shown to be important in metabolizing food, extracting vitamins and nutrients from food, and maintaining a healthy gut lining. The gut microbiome plays an important role in overall health and has been shown to dynamically c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of early-stage triple-negative breast cancer, not on neoadjuvant systemic therapy at the time of enrollment. * Age greater than or equal to 18 years and less than 100 years * English proficiency at or above 8th grade level * Expected survival greater than or equal to…
Contacts

Lee Hong, MD, PhD

858-610-1321

hong.lee@scrippshealth.org

CONTACT

Thomas Buchholz, MD

858-678-7190

buchholz.thomas@scrippshealth.org

CONTACT